Natural and biotech-derived therapeutic proteins: what is the future?
A myriad of novel proteins and ligands of unknown function will be generated by the Human Genomic Project. Due to differences in post-translational processing, proteins produced by recombinant DNA technology may not possess proper biological activity. One way to find their function is to search for their natural counterparts. Proteins are produced in the tissues, and many of them are secreted into plasma and excreted into urine. There is a virtually "unlimited" array of human proteins in our plasma and urine, many of them in a fully active form. They include small molecules like steroids, peptides, and large glycoproteins like human menopausal gonadotropin. A library of plasma and urinary proteins could be developed to serve as a reference for the novel proteins generated by the functional genomic projects.
Liu
T Y
TY
Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan, ROC. dtl@gate.sinica.edu.tw
D005544:Forecasting; D006801:Humans; D020543:Proteome; D011994:Recombinant Proteins / Q000627:therapeutic use*; D014614:Vaccines, Synthetic
D020543:Proteome; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic